Cargando…

EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Regulatory Processes

The importance and merits of greater patient involvement in medicines research and development (R&D) are commonly acknowledged and is thought to offer benefits for all involved parties. It improves discovery, development, and evaluation of new effective medicines, based, among others, on the col...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haerry, David, Landgraf, Cordula, Warner, Kay, Hunter, Amy, Klingmann, Ingrid, May, Matthew, See, Wolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107804/ https://www.ncbi.nlm.nih.gov/pubmed/30175100 http://dx.doi.org/10.3389/fmed.2018.00230

Ejemplares similares

EUPATI Guidance for Patient Involvement in Medicines Research and Development (R&D); Guidance for Pharmaceutical Industry-Led Medicines R&D
por: Warner, Kay, et al.
Publicado: (2018)

EUPATI Guidance for Patient Involvement in Medicines Research and Development: Health Technology Assessment
por: Hunter, Amy, et al.
Publicado: (2018)

EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Ethical Review of Clinical Trials
por: Klingmann, Ingrid, et al.
Publicado: (2018)

The Role of EUPATI CH in Promoting Patient Involvement in Clinical Research: A Multi-Stakeholder Research Project
por: Sessa, Cristiana, et al.
Publicado: (2021)

Improving Patient Involvement in the Lifecycle of Medicines: Insights From the EUPATI BE Survey
por: Grine, Lynda, et al.
Publicado: (2020)

Editorial: The European Patients Academy on Therapeutic Innovation (EUPATI) Guidelines on Patient Involvement in Research and Development
por: Spindler, Per, et al.
Publicado: (2018)

Young patients’ involvement in a composite endpoint method development on acceptability for paediatric oral dosage forms
por: Reidemeister, Sibylle, et al.
Publicado: (2023)

Real-world evidence for regulatory decision-making: updated guidance from around the world
por: Burns, Leah, et al.
Publicado: (2023)

The Specialist in Medicines Development (SMD) as a Vocational Program in Pharmaceutical Medicine: The Japanese and Italian Experience
por: Criscuolo, Domenico, et al.
Publicado: (2020)

Cross-Border Access to Clinical Trials in the EU: Exploratory Study on Needs and Reality
por: Lalova, Teodora, et al.
Publicado: (2020)

Regulatory Information and Guidance on Biosimilars and Their Use Across Europe: A Call for Strengthened One Voice Messaging
por: Barbier, Liese, et al.
Publicado: (2022)

Involvement of the European Medicines Agency in multi-stakeholder regulatory science research projects: experiences of staff members and project coordinators
por: Saesen, Robbe, et al.
Publicado: (2023)

Identification of Novel Modalities Through Bibliometric Analysis for Timely Development of Regulatory Guidance: A Case Study of T Cell Immunity
por: Fukaya-Shiba, Ai, et al.
Publicado: (2021)

Regulatory Standards in Orphan Medicinal Product Designation in the EU
por: Tsigkos, Stelios, et al.
Publicado: (2021)

Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and Practice
por: Janssens, Rosanne, et al.
Publicado: (2018)

Biomarkers in Medicines Development—From Discovery to Regulatory Qualification and Beyond
por: Hendrikse, Natalie M., et al.
Publicado: (2022)

A Composite Endpoint for Acceptability Evaluation of Oral Drug Formulations in the Pediatric Population
por: Wargenau, Manfred, et al.
Publicado: (2022)

A review of patient-reported outcomes used for regulatory approval of oncology medicinal products in the European Union between 2017 and 2020
por: Teixeira, Maria Manuel, et al.
Publicado: (2022)

Regulatory Science to 2025: An Analysis of Stakeholder Responses to the European Medicines Agency's Strategy
por: Hines, Philip A., et al.
Publicado: (2020)

Emerging Radionuclides in a Regulatory Framework for Medicinal Products – How Do They Fit?
por: Decristoforo, Clemens, et al.
Publicado: (2021)

Digital Innovation in Medicinal Product Regulatory Submission, Review, and Approvals to Create a Dynamic Regulatory Ecosystem—Are We Ready for a Revolution?
por: Macdonald, Judith C., et al.
Publicado: (2021)

The latest edition of WHO and ELN guidance and a new risk model for Chinese acute myeloid leukemia patients
por: Wang, Xiaoning, et al.
Publicado: (2023)

POCUS in cardiac arrest and its therapeutic implications – a case report
por: Lim, Wei Yang, et al.
Publicado: (2021)

Guidance for Safety and Dosing of Medicines in Patients With Cirrhosis Is Available
por: Weersink, Rianne A., et al.
Publicado: (2019)

Consensus-based guidance for conducting and reporting multi-analyst studies
por: Aczel, Balazs, et al.
Publicado: (2021)

Machines with vision for intraoperative guidance during gastrointestinal cancer surgery
por: Khalid, Muhammad Uzair, et al.
Publicado: (2022)

Co-design of Guidance for Patient and Public Involvement in Psychedelic Research
por: Close, James B., et al.
Publicado: (2021)

Optimising PCI by Intracoronary Image-guidance
por: Alasnag, Mirvat, et al.
Publicado: (2022)

When Parallel Roads Meet: Orchestrating Collaborations Between Regulatory, Ethical, and Business Partners in Translational Medicine
por: Tabori, Uri, et al.
Publicado: (2019)

Dawn of Monitoring Regulatory T Cells in (Pre-)clinical Studies: Their Relevance Is Slowly Recognised
por: de Wolf, A. Charlotte M. T., et al.
Publicado: (2020)

Direct-to-Consumer Genetic Testing's Red Herring: “Genetic Ancestry” and Personalized Medicine
por: Blell, Mwenza, et al.
Publicado: (2019)

Adopting recommendations for implementing patient involvement in cancer research: a funder’s approach
por: Costa Alencar, Alexandre B., et al.
Publicado: (2023)

Female obesity and infertility: outcomes and regulatory guidance
por: Marinelli, Susanna, et al.
Publicado: (2022)

Editorial: Systemic involvement in obstructive sleep apnea: Personalized medicine to improve health outcomes
por: Labarca, Gonzalo, et al.
Publicado: (2022)

Left ventricular assist device bioinformatics identify possible hubgenes and regulatory networks involved in the myocardium of patients with left ventricular assist device
por: Ajmal, Maryam, et al.
Publicado: (2022)

Fear of fertility side effects is a major cause for COVID-19 vaccine hesitance in infertile patients
por: Kern, Jessica, et al.
Publicado: (2023)

Percutaneous Mitral Valve Repair: Multi-Modality Cardiac Imaging for Patient Selection and Intra-Procedural Guidance
por: Khalique, Omar K., et al.
Publicado: (2019)

Regulatory Authority Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward
por: Sithole, Tariro, et al.
Publicado: (2022)

Evaluation of national institute for health and care excellence guidance for ruptured abdominal aortic aneurysms by emulating a hypothetical target trial
por: Eilenberg, Wolf, et al.
Publicado: (2023)

Case Report: Regulatory T Cell-Independent Induction of Remission in a Patient With Collagenous Colitis
por: Honjo, Hajime, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aqeebim72dkf41bkm82u1hao63